BioCentury
ARTICLE | Finance

It takes two

Tango joins synthetic lethality crowd with $55M series A from Third Rock

March 31, 2017 8:50 PM UTC

Third Rock set up Tango Therapeutics Inc. and provided it with a $55 million A round to use advanced technologies to industrialize the discovery of targets and compounds that can induce synthetic lethality.

While several other companies are working on synthetic lethality, the VC thinks there is room enough for all...

BCIQ Company Profiles

Tango Therapeutics Inc.